| [1] |
Hernández F, Mora L, Tejada J G, et al. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty[J]. Rev Esp Cardiol, 2009, 62(12):1373-1380.
|
| [2] |
王晓燕,肖继伟,万钰磊.碘克沙醇注射液在心血管系统CT注射造影中的安全性评价[J].中国医药导报,2018,15(36):166-169.
|
| [3] |
Zhang B C, Hou L, Lv B, et al. Post-marketing surveillance study with iodixanol in 20185 Chinese patients from routine clinical practices [J]. Br J Radiol, 2013, 99(1034): E247.
|
| [4] |
徐丽婷,巩慧敏,孙爱军,等. 碘克沙醇注射液引起过敏性休克致死亡1例[J].中国药物警戒, 2013,10 (11):701-702.
|
| [5] |
段丹丹,马聪玲. 碘克沙醇注射液致严重过敏反应1例[J]. 中国药物警戒, 2012, 9 (11):704.
|
| [6] |
罗 刚. 碘克沙醇注射液致过敏性休克三例[J]. 医疗装备, 2016, 29(21):198-199.
|
| [7] |
陈立毅. 药物不良反应导致医疗纠纷的分析探讨[J]. 中国医药科学, 2012, 2(8): 130.
|
| [1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(8): 713-715. |
|
|
|
2019, Vol. 30 
